Acquisition supports critical client workflow and reporting
needs with proprietary SaaS platform, automating regulatory report
authoring and compliance across manufacturing operations, supply
chain and quality management
LONDON, April 23,
2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a
leading global provider of transformative intelligence, today
announced that it has acquired Global QMS, Inc., known as Global Q,
a provider of cloud-based solutions that enable life sciences
clients to automate regulatory reporting and compliance management.
Financial terms of the transaction were not disclosed.
Global Q supports leading pharma, medtech and biotech companies
by providing comprehensive access to linked and standardized
workflow-ready data via its SaaS platform, Optiqs360 Digital™. The
platform includes MediGPT - WorkCenter™ and MediGPT -
IntelliWriter™, solutions that provide clients with interconnected
data visibility and common user interfaces, across internal and
external sources of record. The tools support the complex workflows
and reporting needs of clinical, regulatory, product lifecycle and
quality management professionals, significantly streamlining annual
product reviews, medical device reports and supply chain
insights.
Clarivate brings together connected data, deep expertise and
intelligence solutions to empower life sciences and healthcare
companies to deliver safe, effective and commercially successful
treatments to patients faster. The acquisition of Global Q bolsters
a robust integrated platform of life science intelligence solutions
from pre-clinical and clinical offerings and further expands
Clarivate capabilities in manufacturing and supply chain management
to include regulatory report authoring and compliance management.
The workflow and reporting capabilities of Global Q complement the
Clarivate Cortellis Generics Intelligence solution for Active
Pharmaceutical Ingredient (API) tracking. The addition of these
cloud-based solutions will serve to embed Clarivate into critical
client workflows and enable the expansion of Clarivate services
into new markets.
Henry Levy, President, Life
Sciences & Healthcare, Clarivate, said: "Clarivate
continues to explore, develop and integrate next-generation
workflow automation software that streamlines and digitizes manual
workflows. The acquisition of Global Q builds on our strategy to
deliver solutions that empower our clients to advance treatments
that improve patient lives. The combined expertise, data and
technologies of Clarivate and Global Q will help to address the
client need for connected data to support complex analyses and
evidence-based decisions in the life sciences."
Mitch Hayes, Founder &
Chief Executive Officer, Global QMS, Inc., said: "The
acquisition of Global Q by Clarivate reinforces our joint missions
to help global organizations obtain profound insights and
efficiencies in bringing life-saving therapies to their patients
worldwide. The combined business will further the vision of
putting contextually aware intelligence directly into our
customers' workflows and facilitating their daily tasks in ways
never before possible."
Life sciences professionals responsible for new product
development, manufacturing and regulatory compliance are looking to
connect the dots across multiple data points to accelerate their
treatment and prevention efforts and realize better patient health
outcomes. Harmonized and connected data sources can address the
industry need for content authoring automation spanning multiple
systems and workflows. The acquisition of Global Q enables
Clarivate to seamlessly tap into the digital thread market,
allowing for proprietary data and insights gleaned from Clarivate
solutions to frictionlessly be integrated into customer
workflows.
Following the successful acquisition and integration of
companies, including Decision Resources Group (DRG), Bioinfogate,
Patient Connect, Dialog (part of ProQuest) and IP from MotionHall,
the acquisition of Global Q further demonstrates the continuing
investment by Clarivate in high-value data, analytics and
innovative technology paired with deep subject matter and technical
expertise within its Life Sciences and Healthcare segment.
As a trusted partner in shaping the future of healthcare,
Clarivate proactively addresses industry demands through
intelligence platforms that connect data and use AI and advanced
analytics to revolutionize patient engagement, overcome access
barriers and fulfill unmet needs. The complementary solutions of
Clarivate and Global Q will better position the company in a market
that favors innovative tech-enabled providers with end-to-end
capabilities and unique market-leading data sets.
Forward-Looking Statements
This communication contains "forward-looking statements" as defined
in the Private Securities Litigation Reform Act of 1995. These
statements, which express management's current views concerning
future business, events, trends, contingencies, financial
performance, or financial condition, appear at various places in
this communication and may use words like "aim," "anticipate,"
"assume," "believe," "continue," "could," "estimate," "expect,"
"forecast," "future," "goal," "intend," "likely," "may," "might,"
"plan," "potential," "predict," "project," "see," "seek," "should,"
"strategy," "strive," "target," "will," and "would" and similar
expressions, and variations or negatives of these words.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
management's current beliefs, expectations, and assumptions
regarding the future of our business, future plans and
strategies, projections, anticipated events and trends, the
economy, and other future conditions. Because forward-looking
statements relate to the future, they are difficult to predict and
many of which are outside of our control. Important factors that
could cause our actual results and financial condition to differ
materially from those indicated in the forward-looking statements
include those factors discussed under the caption "Risk Factors" in
our most recent annual report on Form 10-K, along with our other
filings with the U.S. Securities and Exchange Commission ("SEC").
However, those factors should not be considered to be a
complete statement of all potential risks and uncertainties.
Additional risks and uncertainties not known to us or that we
currently deem immaterial may also impair our business operations.
Forward-looking statements are based only on information currently
available to our management and speak only as of the date of this
communication. We do not assume any obligation to publicly provide
revisions or updates to any forward-looking statements, whether as
a result of new information, future developments or otherwise,
except as otherwise required by securities and other applicable
laws. Please consult our public filings with the SEC or on our
website at www.clarivate.com.
About Clarivate
Clarivate™ is a leading global provider of transformative
intelligence. We offer enriched data, insights & analytics,
workflow solutions and expert services in the areas of Academia
& Government, Intellectual Property and Life Sciences &
Healthcare. For more information, please
visit www.clarivate.com
About Global QMS, Inc.
Global QMS, Inc., known as
Global Q, is a provider of a cloud-based intelligent workflow
platform that gives our customers an interconnected workspace that
allows them to have a composite view of all their product data
("digital threads"), including internal R&D, post market,
regulatory, manufacturing, and others, as well as external feeds
and real-world data.
Media Contact:
Catherine Daniel, Director, External
Communications
newsroom@clarivate.com
Investor Relations Contact
Mark Donohue, Head of Investor
Relations
investors@clarivate.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/clarivate-acquires-global-qms-inc-expanding-life-sciences--healthcare-segment-into-new-markets-302124068.html
SOURCE Clarivate Plc